Non-Operating Income/Expense (Annual)

Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.

Moderna, Inc. (MRNA) had Non-Operating Income/Expense of $306.00M for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$1.94B
Net Income	$-2.82B
Cost of Goods Sold	$868.00M
Gross Profit	$1.08B
Operating Expenses	$5.02B
Operating Income	$-3.07B
Non-Operating Income/Expense	$306.00M
Pre-Tax Income	$-2.77B
Normalized Pre-Tax Income	$-2.77B
Income after Taxes	$-2.82B
Income from Continuous Operations	$-2.82B
Consolidated Net Income/Loss	$-2.82B
Normalized Income after Taxes	$-2.82B
EBIT	$-3.07B
EBITDA	$-2.93B
Weighted-Average Shares Outstanding (Basic)	389.00M
Weighted-Average Shares Outstanding (Diluted)	389.00M
Earnings per Share (EPS) (Basic)	$-7.26
Earnings per Share (EPS) (Diluted)	$-7.26
Balance Sheet Financials
Current Assets	$6.54B
Property, Plant, and Equipment	$2.13B
Long-Term Assets	$5.79B
Total Assets	$12.34B
Current Liabilities	$1.99B
Long-Term Debt	$610.00M
Long-Term Liabilities	$1.70B
Total Liabilities	$3.69B
Common Equity	$8.65B
Tangible Shareholders Equity	$8.65B
Shareholders Equity	$8.65B
Common Shares Outstanding	394.00M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-1.87B
Cash Flow from Investing Activities	$1.95B
Cash Flow from Financial Activities	$593.00M
Beginning Cash	$1.93B
End Cash	$2.60B
Increase/Decrease in Cash	$668.00M
Stock-Based Compensation	$483.00M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.29
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.07
Debt to Equity Ratio	0.07
Gross Margin	55.35%
Operating Margin	-158.13%
EBIT Margin	-158.13%
EBITDA Margin	-150.51%
Pre-Tax Profit Margin	-142.39%
Profit Margin	-145.16%
Free Cash Flow	$-2.06B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.16
Inventory Turnover	5.67
Receiveable Turnover	10.57
Days Sales in Receivables	34.55
Return on Equity	-32.62%
Return on Tangible Equity	-32.62%
Return on Assets	-22.87%
Return on Investments	-30.48%
Book Value Per Share	$21.95
Free Cash Flow per Share	$-5.31
Operating Cash Flow per Share	$-4.81

Data from Zacks Investment Research, Inc.